News Tag: 2021 newsletters
Get to Know the Protocol Support Committee (PSC)
Read More
Why Should We Participate in NRG-CC005/FORTE?
Read More
Phase 3 Trial Combining Two Alkylating Agents with Radiotherapy for Newly Diagnosed Glioblastoma (NRG-BN011)
Read More
Phase 3, Node-Positive Prostate Cancer Trial Reactivates Following Change to Experimental Treatment Arm (NRG-GU008, the INNOVATE trial)
Read More
Mei-Yin C. Polley, PhD Re-elected to Serve as the Biostatistician on the NCI Head & Neck Steering Committee
Read More
Background: National Coverage Analysis
Read More
The NRG-CC005 (FORTE) Trial has Activated!
Read More
Comparing High- and Low-Dose Cisplatin for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (NRG-HN009)
Read More
New Prostate Cancer Study Testing Higher-intensity Treatment for Patients with Higher Gene Risk Scores and Lower-intensity Treatment for Patients with Lower Gene Risk Scores (NRG-GU010, the GUIDANCE trial)
Read More
The University of Michigan T32 in Cancer Care Delivery Accepts First Cohort of Pre- and Post- Doctoral Scholars
Read More